34 results
Page 2 of 2
8-K
EX-99.1
qmhafa
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.2
akm aqfwk7w4end
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
0jh5wma1ybthamw
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
qmz5s i1zizxu763p
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
w8ct j19yxugebuncqs
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
EX-99.2
kgvksxcpl8juyckml7q
28 Jan 21
Other Events
4:05pm
8-K
EX-99.1
1wrctj
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
8-K
0e647c35
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
8-K
EX-99.1
t83i0n
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
S-1
EX-10.35
fge6d2m
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.16
k9bgzk 90b3933e
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.16
crvj2entssret blp
7 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.35
rdwmkp ac
7 Aug 19
Draft registration statement (amended)
12:00am